Literature DB >> 8816389

IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma.

K Kichian1, F P Nestel, D Kim, P Ponka, W S Lapp.   

Abstract

The onset of acute graft-vs-host disease (aGVHD) is accompanied by macrophage (M phi) priming and the presence of bacteria-derived LPS in the sera of transplanted animals. Priming of M phi occurs during aGVHD despite the suppression of T cell function. We have investigated whether IL-12 mediates the continued production of IFN-gamma during the state of T cell immunosuppression that accompanies aGVHD. Acute GVHD was induced in nonirradiated AxC57BL/6F1 mice by the injection of C57BL/6 lymphoid cells. Despite T cell immunosuppression, M phi became primed, as shown by their expression of inducible nitric oxide synthase mRNA and their production of nitric oxide in response to LPS. Continual exposure to IFN-gamma was required to maintain a primed state in M phi during aGVHD. IL-12 p40 peptide mRNA was increased in M phi purified from animals undergoing aGVHD 14 days after transplantation. Target organs of aGVHD, including thymus, salivary gland, and lung, showed increased IFN-gamma mRNA between days 7 and 14 after transplantation. The increase was accompanied by an induction of mRNA for the p40 peptide of IL-12 and inducible nitric oxide synthase within the target organs. These results provide evidence for localized production of IFN-gamma within aGVHD target organs and suggest that it is mediated by LPS-induced production of IL-12 by M phi. Our data elucidate the mechanism of activation of M phi during aGVHD that results in TNF-alpha and nitric oxide production and delineates the effector role of M phi in the pathology of aGVHD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Deficiency in tumor necrosis factor alpha activity does not impair early protective Th1 responses against blood-stage malaria.

Authors:  H Sam; Z Su; M M Stevenson
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells.

Authors:  H Matsumoto; K Suzuki; K Tsuyuguchi; E Tanaka; R Amitani; A Maeda; K Yamamoto; M Sasada; F Kuze
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.

Authors:  Yongxia Wu; David Bastian; Steven Schutt; Hung Nguyen; Jianing Fu; Jessica Heinrichs; Changqing Xia; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-04       Impact factor: 5.742

4.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria.

Authors:  H Sam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.

Authors:  G R Hill; T Teshima; A Gerbitz; L Pan; K R Cooke; Y S Brinson; J M Crawford; J L Ferrara
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

7.  IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Authors:  T Teshima; G R Hill; L Pan; Y S Brinson; M R van den Brink; K R Cooke; J L Ferrara
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

Authors:  Rainer Ordemann; Raymond Hutchinson; Jeffrey Friedman; Steven J Burakoff; Pavan Reddy; Ulrich Duffner; Thomas M Braun; Chen Liu; Takanori Teshima; James L M Ferrara
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

9.  Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.

Authors:  Y Onoe; M Harada; K Tamada; K Abe; T Li; H Tada; K Nomoto
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  G R Hill; K R Cooke; T Teshima; J M Crawford; J C Keith; Y S Brinson; D Bungard; J L Ferrara
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.